EUCTR2005-000865-21-IT进行中（未招募）不适用
A phase IV, open-label, randomized, multicenter trial assessing the efficacy of a treatment maintenance phase with unboosted vs boosted Reyataz after an induction phase with Reytaz and Ritonavir in treatment naive HIV patients
BRISTOL-M.SQUIBB0 个研究点开始时间: 2006年1月30日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A phase IV, open-label, randomized, multicenter trial assessing a reyataz-based substitution approach in the management of lipodystrophy syndrome.HIVMedDRA version: 6.1Level: PTClassification code 10049287EUCTR2004-002740-10-ITBRISTOL-M.SQUIBB300
进行中（未招募）
不适用
A phase IV, randomized, open-label, multi-center study in adults: Evaluation of long-term immunogenicity in subjects boosted with a new TBE vaccine for adults (free of protein-derived stabilizer) in study V48P2E1, 5 years after first booster immunization and Evaluation of booster kinetics in subjects boosted with a new TBE vaccine for adults (free of protein-derived stabilizer), 5 years after first booster immunization. - not availableTBE prophylaxisEUCTR2005-004459-36-DEChiron Behring GmbH & Co KG190
已完成
4 期
Immunogenicity and safety of Rabies Vaccine, adimistered with two different simulated post exposure regimensCTRI/2011/07/001857ovartis Healthcare Pvt Ltd250
进行中（未招募）
1 期
Study of management of pasireotide-induced hyperglycemia in adult patients with Cushing’s disease or acromegalyEUCTR2012-002916-16-BEovartis Pharma Services AG132
进行中（未招募）
1 期
Study of management of pasireotide-induced hyperglycemia in adult patients with Cushing’s disease or acromegalyCushing's disease and acromegalyMedDRA version: 19.0Level: LLTClassification code 10011651Term: Cushing's diseaseSystem Organ Class: 100000004860MedDRA version: 19.0Level: LLTClassification code 10000600Term: Acromegaly and gigantismSystem Organ Class: 100000004860EUCTR2012-002916-16-PLovartis Pharma Services AG133